These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 21586354)

  • 41. Human Adenosine A
    Carpenter B; Lebon G
    Front Pharmacol; 2017; 8():898. PubMed ID: 29311917
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Demystifying the three dimensional structure of G protein-coupled receptors (GPCRs) with the aid of molecular modeling.
    Moro S; Deflorian F; Spalluto G; Pastorin G; Cacciari B; Kim SK; Jacobson KA
    Chem Commun (Camb); 2003 Dec; (24):2949-56. PubMed ID: 14703805
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Characteristic molecular vibrations of adenosine receptor ligands.
    Chee HK; Yang JS; Joung JG; Zhang BT; Oh SJ
    FEBS Lett; 2015 Feb; 589(4):548-52. PubMed ID: 25622891
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Adenosine receptors: what we know and what we are learning.
    Trincavelli ML; Daniele S; Martini C
    Curr Top Med Chem; 2010; 10(9):860-77. PubMed ID: 20370662
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Topology of class A G protein-coupled receptors: insights gained from crystal structures of rhodopsins, adrenergic and adenosine receptors.
    Mustafi D; Palczewski K
    Mol Pharmacol; 2009 Jan; 75(1):1-12. PubMed ID: 18945819
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Adenosine receptors interacting proteins (ARIPs): Behind the biology of adenosine signaling.
    Ciruela F; Albergaria C; Soriano A; Cuffí L; Carbonell L; Sánchez S; Gandía J; Fernández-Dueñas V
    Biochim Biophys Acta; 2010 Jan; 1798(1):9-20. PubMed ID: 19883624
    [TBL] [Abstract][Full Text] [Related]  

  • 47. C(X)CR in silico: Computer-aided prediction of chemokine receptor-ligand interactions.
    Roumen L; Scholten DJ; de Kruijf P; de Esch IJ; Leurs R; de Graaf C
    Drug Discov Today Technol; 2012; 9(4):e281-91. PubMed ID: 24990665
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Kinetic Aspects of the Interaction between Ligand and G Protein-Coupled Receptor: The Case of the Adenosine Receptors.
    Guo D; Heitman LH; IJzerman AP
    Chem Rev; 2017 Jan; 117(1):38-66. PubMed ID: 27088232
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Molecular Basis of Modulating Adenosine Receptors Activities.
    Mahmod Al-Qattan MN; Mordi MN
    Curr Pharm Des; 2019; 25(7):817-831. PubMed ID: 30834826
    [TBL] [Abstract][Full Text] [Related]  

  • 50. PET Imaging of Adenosine Receptors in Diseases.
    Li J; Hong X; Li G; Conti PS; Zhang X; Chen K
    Curr Top Med Chem; 2019; 19(16):1445-1463. PubMed ID: 31284861
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Adenosine Receptors in Neuropsychiatric Disorders: Fine Regulators of Neurotransmission and Potential Therapeutic Targets.
    Pasquini S; Contri C; Merighi S; Gessi S; Borea PA; Varani K; Vincenzi F
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163142
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Molecular probes for the human adenosine receptors.
    Yang X; Heitman LH; IJzerman AP; van der Es D
    Purinergic Signal; 2021 Mar; 17(1):85-108. PubMed ID: 33313997
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A role for a specific cholesterol interaction in stabilizing the Apo configuration of the human A(2A) adenosine receptor.
    Lyman E; Higgs C; Kim B; Lupyan D; Shelley JC; Farid R; Voth GA
    Structure; 2009 Dec; 17(12):1660-1668. PubMed ID: 20004169
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Crystal structures of the A
    Jacobson KA
    In Silico Pharmacol; 2013 Dec; 1():22. PubMed ID: 24660138
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Implementing the "Best Template Searching" tool into Adenosiland platform.
    Floris M; Sabbadin D; Ciancetta A; Medda R; Cuzzolin A; Moro S
    In Silico Pharmacol; 2013; 1():25. PubMed ID: 25505667
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Non-Nucleoside Agonists of the Adenosine Receptors: An Overview.
    Dal Ben D; Lambertucci C; Buccioni M; Martí Navia A; Marucci G; Spinaci A; Volpini R
    Pharmaceuticals (Basel); 2019 Oct; 12(4):. PubMed ID: 31597388
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Chronic salt loading and the expression of adenosine receptor subtypes.
    Nayeem MA; Olanrewaju HA; Mustafa SJ; Li PL; Cowley AW
    Hypertension; 1999 Dec; 34(6):e18-9. PubMed ID: 10601139
    [No Abstract]   [Full Text] [Related]  

  • 58. Biochemical characterization of adenosine deaminase (CD26; EC 3.5.4.4) activity in human lymphocyte-rich peripheral blood mononuclear cells.
    Costa LR; Souza AKY; Scholl JN; Figueiró F; Battastini AMO; Jaques JADS; Zanoelo FF
    Braz J Med Biol Res; 2021; 54(8):e10850. PubMed ID: 34037096
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Molecular Determinants of CGS21680 Binding to the Human Adenosine A2A Receptor.
    Lebon G; Edwards PC; Leslie AG; Tate CG
    Mol Pharmacol; 2015 Jun; 87(6):907-15. PubMed ID: 25762024
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The structure of the adenosine receptors: implications for drug discovery.
    Lane JR; Jaakola VP; Ijzerman AP
    Adv Pharmacol; 2011; 61():1-40. PubMed ID: 21586354
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.